RecruitingNot ApplicableNCT05711888

Semantic Recognition Task (SRT) in Alzheimer Disease

A Sensitive Measurement Proposal in Alzheimer's Disease: Semantic Recognition Task


Sponsor

Istanbul University

Enrollment

80 participants

Start Date

Dec 21, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to observe the outcomes of a semantic recognition task in Alzheimer Disease and discuss what this might add to clinical practice.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is testing a new memory assessment tool called the Semantic Recognition Task (SRT) — a test that measures how well a person recognizes and understands word meanings — in people who have already undergone biomarker testing for Alzheimer's disease. The goal is to see whether the SRT can help detect Alzheimer's disease or track its progression, and whether it performs differently in people whose biomarker tests were positive versus negative. **You may be eligible if...** - You have already had biomarker testing for Alzheimer's disease (whether the result was positive or negative) - You are able to read **You may NOT be eligible if...** - You are unable to read (illiteracy is an exclusion criterion, as the task requires reading) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSemantic Recognition Procedure

A semantic recognition task is going to be added to administrated FCSRT procedure after immediate and delayed recall phases.


Locations(1)

Jbid Dursun Uncu

Beşiktaş, Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05711888


Related Trials